Monitor post-meeting filings for any share issuance or equity award grants under the new plan. The share authorization increase could precede a future capital raise.
Price Chart
Executive Summary
Spero Therapeutics filed additional proxy materials for its 2026 Annual Meeting, scheduled for June 23, 2026. Proposals include electing two Class III directors, ratifying the auditor, advisory vote on executive compensation, doubling authorized shares from 120M to 240M, and adopting a new stock incentive plan. The board recommends a 'For' vote on all items.
Key Facts
- Annual meeting set for June 23, 2026
- Proposal to increase authorized common shares from 120,000,000 to 240,000,000
- Proposal to adopt the 2026 Spero Therapeutics, Inc. Stock Incentive Plan
- All five proposals are recommended 'For' by the board
- Market cap ~$159M with mixed analyst consensus
Financial Impact
Potential dilution from doubling authorized shares, but no immediate issuance announced.
Risk Factors
- Future dilution from authorized share increase
- Potential overhang if new equity issuance is announced
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182256 |
| Document: 0001193125-26-182256-index-headers.html | 0001193125-26-182256 |
| Document: 0001193125-26-182256-index.html | 0001193125-26-182256 |
| Document: 0001193125-26-182256.txt | 0001193125-26-182256 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | EFFECT | $1.13 $1.13 | · 0.00% | ▼ −0.34% | $1.20 (−6.19%) |
Aug 28, 2026 4w ago | 8-K | $1.22 $1.19 | ▲ +2.46% | ▲ +2.32% | $1.20 (+1.64%) |
Aug 28, 2026 4w ago | S-3 | $1.22 $1.19 | ▲ +2.46% | ▲ +2.32% | $1.20 (+1.64%) |
Aug 12, 2026 7w ago | Press Release | $1.24 $1.22 | ▼ −1.61% | ▲ +0.35% | $1.20 (−3.23%) |
Jul 14, 2026 11w ago | 8-K | $1.70 $1.44 | ▼ −15.29% | ▼ −14.00% | $1.20 (−29.41%) |
Jul 14, 2026 11w ago | Press Release | $1.70 $1.44 | ▼ −15.29% | ▼ −14.00% | $1.20 (−29.41%) |
Jun 25, 2026 14w ago | 8-K | $2.26 $2.20 | ▼ −2.65% | ▼ −4.82% | $1.20 (−46.90%) |
Jun 22, 2026 14w ago | 8-K | $2.15 $2.26 | ▲ +5.12% | ▲ +4.10% | $1.20 (−44.19%) |
Jun 17, 2026 15w ago | Press Release | $2.11 $2.10 | ▼ −0.47% | ▲ +0.57% | $1.20 (−43.13%) |
May 13, 2026 20w ago | 8-K | $2.76 $2.69 | ▼ −2.54% | ▼ −1.82% | $1.20 (−56.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access